CarolH(Hatch)WyshamMD(She/Her)

Diabetes, Lipid Metabolism, Thyroid

Endocrinologist, Rockwood/Multicare Center for Diabetes and Endocrinology

Dr. Wysham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
400 E 5th Ave
# 4W
Spokane, WA 99202
Phone+1 509-838-2531

Fax+1 509-342-3451

Dr. Carol Wysham is an endocrinologist in Spokane, WA and is affiliated with multiple hospitals in the area, including MultiCare Deaconess Hospital and MultiCare Valley Hospital. She received her medical degree from University of Iowa Carver College of Medicine and has been in practice 37 years. She specializes in diabetes, lipid metabolism, and thyroid.

University of Iowa Hospitals and ClinicsFellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1986
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1980 - 1983
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1980

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Diabetes Recognition Program National Committee for Quality Assurance, 2012-2015
Fellow (FACE) American Association of Clinical Endocrinology

PubMed

Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment.
Carol Wysham, Harpreet S Bajaj, Stefano Del Prato, Denise Reis Franco, Arihiro Kiyosue
The New England Journal of Medicine. 2024-12-12
Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics.
Christophe De Block, Jennifer Peleshok, John P H Wilding, Anita Y M Kwan, Neda Rasouli
Diabetes Therapy. 2024-11-12
2 citations
Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens.
Gregg D Simonson, Amy B Criego, Tadej Battelino, Anders L Carlson, Pratik Choudhary
Diabetes Technology & Therapeutics. 2024-11-01

Journal Articles

Day‐to‐Day Fasting Self‐Monitored Blood Glucose Variability Is Associated with Risk of Hypoglycaemia in Insulin‐Treated Patients with Type 1 and Type 2 Diabetes: A Pos...
Gregg Gerety, Anuj Bhargava, Carol H Wysham, Diabetes, Obesity and Metabolism

Lectures

Insulin Analogs and Diabetes Technology: Past, Present, and Future
ENDO 2019 - New Orleans, LA - 3/25/2019
Master Clinician: Management of Diabetes: Selecting Therapy Based on CVD Outcomes and Beyond
ENDO 2019 - New Orleans, LA - 3/24/2019
New Treatments for Type 1 Diabetes and the Pathophysiology of Microvascular Complications
ENDO 2019 - New Orleans, LA - 3/24/2019
A Post Hoc Pooled Analysis to Evaluate Hypoglycaemia Risk with Insulin Glargine 300 U/mL (Gla‐300) Versus 100 U/mL (Gla‐100) over Wider Nocturnal Windows in People wit...
ENDO 2019 - New Orleans, LA - 3/24/2019
Join now to see all

Abbott’s FreeStyle Libre CGM Systems Now Cleared for Use During Imaging ProceduresOctober 30th, 2024
Abbott CGM Sensors Can Now Be Worn During Common Imaging ProceduresOctober 30th, 2024
Once-Weekly Insulin as Effective as Daily Injections for Patients with Type 2 DiabetesSeptember 14th, 2024
Join now to see all